BTIG Maintains Buy on Boston Scientific, Raises Price Target to $64
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Marie Thibault has maintained a 'Buy' rating on Boston Scientific (NYSE:BSX) and raised the price target from $62 to $64.
September 21, 2023 | 2:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific's price target has been raised from $62 to $64 by BTIG, which maintains a 'Buy' rating on the stock.
The raised price target indicates that the analyst sees potential for the stock's price to increase. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100